Indications and uses
relieves occasional constipation (irregularity) this product generally produces a bowel movement in 6 to 12 hours
relieves occasional constipation (irregularity) this product generally produces a bowel movement in 6 to 12 hours
take preferably at bedtime or as directed by a doctor age starting dosage maximum dosage adults and children 12 years of age or older 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a docto
each tablet contains: calcium 4 mg, sodium 3 mg store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
Senna Tablets
Sennosides 8.6 mg
AACE Pharmaceuticals, Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Sennosides 8.6 mg
Laxative
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| age | starting dosage | maximum dosage |
| adults and children 12 years of age or older | 2 tablets once a day | 4 tablets twice a day |
| children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a docto |
colloidal silicon dioxide, croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, stearic acid
Sennosides 8.6 mg Tablet
Repackaged/Relabeled by:
Bryant Ranch Prepack, Inc.
Burbank, CA 91504
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-8896-1 | EA - Each | 63629-8896 | df74720f-6b72-4254-a50c-19552b3b2cbd | 1 | 2022-01-06 |
| 71406-105-01 | EA - Each | 71406-105 | 1c4ca8dd-59d6-498a-a0fb-024932d4ae22 | 1 | 2021-11-09 |
| 71406-105-10 | EA - Each | 71406-105 | 53afb42b-8473-41e5-9bea-2a02df8f9ae4 | 1 | 2021-11-09 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63629-8896 | 63629-8896-1 |
| 71406-105 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| SENNOSIDES | 3FYP5M0IJX | ACTIB |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f2d11913-887a-49b7-90ca-88f768309d5b | 5f98de04-bb0c-4f03-b77c-ba690f99983a | 2024-09-25 | Warnings | 5f98de04-bb0c-4f03-b77c-ba690f99983a |
Adverse event summaries are temporarily unavailable. Other product information remains available.